Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-17

Clinical Trial Update: A Pilot Study of Vitamin K2 (Menaquinone-7, Soloways ™) in Patients With Osteopenia/Osteoporosis Carrying a VDR Gene Variant [NA]

View source ↗

Summary

An ongoing pilot study evaluating the safety and potential bone-health effects of vitamin K2 (menaquinone-7) in adults with osteopenia or osteoporosis who carry…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Soloways Vitamin K2 (menaquinone-7) (menaquinone-7)

Snippet

Sponsor: S.LAB (SOLOWAYS) | Conditions: Osteoporosis, Osteopenia | NA | Status: RECRUITING